IFGL's Khurda timeline slips and Monocon breakeven delayed after customer loss
Management dropped its firm FY28 completion target for the ₹300-350 cr greenfield and pushed Monocon's breakeven to Q4 FY27, citing a lost UK customer it hadn't disclosed before.
What's new
- FY26 consolidated revenue was ₹1,904 cr, up 14% YoY; EBITDA margin was 7.7%.
- The US business grew 25% in FY26 with high-teen EBITDA margins, recovered to five-year highs.
- Domestic revenue grew 20% to ₹860 cr in FY26, but Q4 growth slowed to 7%.
- Board recommended a dividend of ₹21.5 per share for FY26.
Themes from the call
Guidance rollback
Two previously firm commitments—Khurda timeline and Monocon breakeven—have been diluted or delayed in the same quarter.
Domestic momentum
India revenue grew 20% in FY26 on market share gains and full-range refractory solutions, but Q4 decelerated to 7% growth.
US recovery
The US subsidiary recovered to high-teen EBITDA margins on 25% revenue growth, which management called sustainable.
Cost inflation
Management is in price revision discussions with customers to pass through raw material and logistics cost increases, with no timeline given.
Guidance watch
- Khurda greenfield: Previous 'firmly on schedule' target of end-FY28 (₹300-350 cr investment) replaced with a vague 'evaluating pace and structure' note.
- Monocon breakeven: Delayed from 'early FY27' to Q4 FY27 after a high-margin UK customer was lost to a plant closure.
- FY27 India growth: Management guided for 'minimum double-digit' domestic revenue growth, which it called directional.
- Technology transfer: Sheffield Refractories phase 1 complete; full India market entry for plastic ramming mass targeted end-CY27.
Risk flags
- The Khurda project's new vagueness on timeline and structure suggests either cost escalation, regulatory delays, or a reassessment of market need.
- Monocon's new customer loss was not disclosed previously, raising questions about transparency on subsidiary risks.
- Raw material and logistics inflation is acknowledged, but management offered no specific pass-through timeline or magnitude.
- Q4 domestic growth slowed to 7% from the full-year 20%, which may signal demand moderation or competitive pressure.
Key quotes
-
"Our US operations have managed to regain double-digit EBITDA margins, recapturing margin levels from 5 years ago."
— IFGL Management -
"The board continues to evaluate the pace and structure of future investment in line with evolving market conditions and strategic priorities."
— IFGL Management, on the Khurda project
The brief
IFGL Refractories had a solid operational quarter but a messy one for forward guidance. The company delivered 14% consolidated revenue growth in FY26 and its US subsidiary recovered to high-teen EBITDA margins on 25% topline growth. That part of the story holds up.
The problem is credibility on two big commitments. The Khurda greenfield project, which management had said was 'firmly on schedule' for end-FY28 completion, is now under review. The board is 'evaluating the pace and structure,' which is corporate language for a delay. Separately, Monocon UK's breakeven target was pushed from early FY27 to Q4 FY27 after the undisclosed loss of a key high-margin customer due to a plant closure. The customer loss wasn't mentioned in prior calls.
Domestic growth decelerated to 7% in Q4 from 20% for the full year. Management is in price revision discussions to pass through raw material and logistics inflation but gave no timeline or magnitude. The elimination of a ₹6.7 cr annual negative goodwill charge will help FY27 reported earnings, but that's a technicality, not a business driver.
The investment case now rests on whether management can deliver on three things: sustaining US margins at five-year highs, closing the domestic price revision talks, and restoring clarity on Khurda. The first looks achievable. The second is in progress. The third is now an open question.
IFGL's operational recovery is real, but two guidance walk-backs in one quarter make the next phase harder to trust.